-
Impact with equity: EDCTP and equitable research partnerships
Makanga, M., Beattie, P., Jajkowicz, D., Nyirenda, T., Tanner, M. & Hankins, C., 1 Apr 2024, In: The Lancet Global Health. 12, 4, p. e552-e554Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
Mahomed, S., Garrett, N., Potloane, D., Sikazwe, I. T., Capparelli, E., Harkoo, I., Gengiah, T. N., Zuma, N. Y., Osman, F., Mansoor, L., Archary, D., Myeni, N., Radebe, P., Samsunder, N., Rose, N. D., Carlton, K., Gama, L., Koup, R. A., Narpala, S., Serebryannyy, L., & 7 others, 28 Aug 2023, In: BMJ Open. 13, 8, p. e076843 9 p., e076843.Research output: Contribution to journal › Article › Academic › peer-review
-
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
the COVID-19 Immunity Task Force (CITF) working group, Sept 2022, In: Heliyon. 8, 9, 12 p., e10270.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
